SALT LAKE CITY, UTAH; March 17, 2026 – Today, Kurt Miceli, MD, Do No Harm’s Chief Medical Officer, will present to the Centers for Disease Control and Prevention (CDC) about the need for new medical diagnosis codes (known as ICD-10 codes) for gender transition and detransition.
“Refining the medical diagnosis codes for gender transition and detransition is urgently needed. Currently, the lack of a specific code for detransition makes these individuals effectively invisible to the healthcare system, obscuring their medical needs and limiting real-world research, follow‑up care, and outcome monitoring that responsible practice requires,” said Kurt Miceli, MD, Chief Medical Officer at Do No Harm. “The new diagnosis codes we’re proposing would help generate valuable research data, support evidence-based health standards, and enhance patient care. We commend the CDC for taking important steps toward this goal by accepting for October implementation the code we introduced at the last ICD-10 meeting: gender identity disorder in remission, or desistance. We encourage the agency to adopt our newly proposed codes so that we can further improve the quality of research and care for those suffering from gender dysphoria.”
The CDC meeting will begin at 9:00 a.m. ET. Click here for the agenda and livestream.
Why new codes are needed:
Do No Harm’s proposed codes aim to more precisely capture the various aspects of gender transition, distinguish those aspects from disorders of sex development, and make sure detransitioners are fully visible to the healthcare system.
These codes include:
Do No Harm, established in April 2022, has rapidly gained recognition and made significant strides in its mission to safeguard healthcare from ideological threats. It has over 50,000 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and 14 countries.
